Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic

Optimal timing of treatment at relapse after autologous stem cell transplantation in patients with multiple myeloma: a study of the Korean Multiple Myeloma Working Party (KMM-1909)

Baseline patient characteristics and PROs

Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life - ScienceDirect

Preventing osteolytic lesions and osteomyelitis in multiple myeloma - ScienceDirect

OUH - Group members

Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry

Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life

Progression-free (PFS) and overall survival (OS) landmark analysis from

The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma, Experimental Hematology & Oncology

Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option

Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE

PDF) Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the

Health-related quality of life in the ENDEAVOR study: carfilzomib- dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma

Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review - ScienceDirect

Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review - ScienceDirect

PDF] Validating the CORE-10 as a mental health screening tool for prisoners

Full article: The adaptation of a community-based suicide prevention intervention during the COVID19 pandemic: a mixed method study

What do the colours on the pathway heatmaps represent? - FastBMD - OmicsForum

Here Are the Scoring Charts for the Air Force's New PT Test Exercises—Minus the Walk

Scaling Up Talent Assessment Chart / 9-Box Grid. Locating the A